References
- Murthy R, Brown DB, Salem R et al. Gastrointestinal complications associated with hepatic arterial Yttrium-90 microsphere therapy. J. Vasc. Interv. Radiol.18, 553–561 (2007).
- Geschwind JF, Salem R, Carr BI et al. Yttrium-90 microspheres for the treatment of hepatocellular carcinoma. Gastroenterology127, S194–S205 (2004).
- Kulik LM, Atassi B, van Holsbeeck L et al. Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation. J. Surg. Oncol.94, 572–586 (2006).
- Kulik LM, Carr BI, Mulcahy MF et al. Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis. Hepatology47, 71–81 (2008).
- Raoul JL, Guyader D, Bretagne JF et al. Prospective randomized trial of chemoembolization versus intra-arterial injection of 131I-labeled-iodized oil in the treatment of hepatocellular carcinoma. Hepatology26, 1156–1161 (1997).
- Brown DB, Cardella JF, Sacks D et al. Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy. J. Vasc. Interv. Radiol.17, 225–232 (2006).
- Bernal P, Raoul JL, Vidmar G et al. Intra-arterial rhenium-188 lipiodol in the treatment of inoperable hepatocellular carcinoma: results of an IAEA-sponsored multination study. Int. J. Radiat. Oncol. Biol. Phys.69, 1448–1455 (2007).
- Kim JK, Han KH, Lee JT et al. Long-term clinical outcome of phase IIb clinical trial of percutaneous injection with holmium-166/chitosan complex (Milican) for the treatment of small hepatocellular carcinoma. Clin. Cancer Res.12, 543–548 (2006).
- Wang XM, Yin ZY, Yu RX, Peng YY, Liu PG, Wu GY. Preventive effect of regional radiotherapy with phosphorus-32 glass microspheres in hepatocellular carcinoma recurrence after hepatectomy. World J. Gastroenterol.14, 518–523 (2008).
- Carr BI, Brown M, France M, Rosen J, Sheetz M, Zajko A. 90Yttrium labeled glass microspheres in the treatment of hepatocellular carcinoma: initial US experience. Proc. ASCO20, 2346 (2001).
- Salem R, Thurston KG, Carr BI, Goin JE, Geschwind JFH. Yttrium-90 microspheres: radiation therapy for unresectable liver cancer. J. Vasc. Interventional Radiol.13(9), S223–S229 (2002).
- Carr BI. Hepatic arterial 90Y glass microspheres (Therasphere®) for unresectable hepatocellular carcinoma: Interim safety and survival data on 65 patients. Liver Transplant.10(2), S107–S110 (2004).
- Goin JE, Salem R, Carr BI et al. Treatment of unresectable HCC with intrahepatic Yttrium 90 microspheres; factors associated with liver toxicities. J. Vasc. Interventional Radiol.16, 205–213 (2005).
- Geschwind J, Salem R, Carr B et al. Yttrium-90 microspheres for the treatment of hepatocellular carcinoma. Gastroenterology127, S194–S205 (2004).
- Carr BI, Amesur NB, Dasyam A. A randomized, controlled study of TACE versus 90Yttrium microspheres for treatment of unresectable HCC: interim results. Proc. Am. Assoc. Clin. Oncol.26(Suppl.) (2008) (Abstract 15609).